enGene Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Saint Laurent
SEC filing record 1 source field available
Fiscal year end
31 October
enGene Therapeutics Inc. has filed 267 SEC EDGAR filings since 14 Jun 2023

SEC filing history

Showing 176-200 of 267 matching filings.

Per page
25
Current page
8
424B3 File 333-275700

424B3

Filing date
25 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
22 Apr 2024
Reporting date
18 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-41854

ARS

Filing date
18 Apr 2024
Reporting date
31 Oct 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-41854

DEF 14A

Filing date
18 Apr 2024
Reporting date
15 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Mar 2024
Reporting date
21 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
20 Mar 2024
Reporting date
18 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Mar 2024
Reporting date
15 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-275700

424B3

Filing date
12 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-275700

EFFECT filing

Filing date
05 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-275700

424B3

Filing date
05 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
04 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-277378

S-8

Filing date
27 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94211

SC 13G

Filing date
26 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94211

SC 13G filing

Filing date
23 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94211

SC 13G

Filing date
23 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-94211

AMENDMENT NO. 1 TO SCHEDULE 13G

Filing date
22 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Feb 2024
Reporting date
20 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-94211

SC 13D/A

Filing date
21 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-94211

SC 13G

Filing date
14 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .